Lateral flow assay-based detection of nuclear fusion oncoprotein: implications for screening of acute promyelocytic leukemia.

Chabi M, Vu B, Brosamer K, Song S, Maranholkar V, Zeng Z, Zu Y, Kanagal-Shamanna R, Conrad JC, Willson RC, Kourentzi K.

Open source

DOI
10.1039/d4sd00357h
Published
2025-03-21
Container
Sens Diagn
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1039/d4sd00357h,
  title = {Lateral flow assay-based detection of nuclear fusion oncoprotein: implications for screening of acute promyelocytic leukemia.},
  author = {Chabi M and  Vu B and  Brosamer K and  Song S and  Maranholkar V and  Zeng Z and  Zu Y and  Kanagal-Shamanna R and  Conrad JC and  Willson RC and  Kourentzi K.},
  year = {2025},
  journal = {Sens Diagn},
  doi = {10.1039/d4sd00357h},
  url = {https://doi.org/10.1039/d4sd00357h}
}

RIS

TY  - JOUR
TI  - Lateral flow assay-based detection of nuclear fusion oncoprotein: implications for screening of acute promyelocytic leukemia.
AU  - Chabi M
AU  -  Vu B
AU  -  Brosamer K
AU  -  Song S
AU  -  Maranholkar V
AU  -  Zeng Z
AU  -  Zu Y
AU  -  Kanagal-Shamanna R
AU  -  Conrad JC
AU  -  Willson RC
AU  -  Kourentzi K.
PY  - 2025
JO  - Sens Diagn
DO  - 10.1039/d4sd00357h
UR  - https://doi.org/10.1039/d4sd00357h
ER  - 

APA

M, C., B, V., K, B., S, S., V, M., Z, Z., Y, Z., R, K., JC, C., RC, W., & K., K. (2025). Lateral flow assay-based detection of nuclear fusion oncoprotein: implications for screening of acute promyelocytic leukemia.. Sens Diagn. https://doi.org/10.1039/d4sd00357h

Source records